Dr. Boorjian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511Fax+1 507-284-0161
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2002 - 2006- New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2000 - 2002
Harvard Medical SchoolClass of 2000
Certifications & Licensure
IA State Medical License 2022 - 2026
IL State Medical License 2022 - 2026
ND State Medical License 2022 - 2026
MN State Medical License 2010 - 2025
WI State Medical License 2022 - 2025
PA State Medical License 2008 - 2010
NY State Medical License 2001 - 2009- American Board of Urology Urology
Awards, Honors, & Recognition
- Young Urologist of the Year American Urological Association, 2014
- AUA-EAU Academic Exchange Program Scholar 2014
- Teacher of the Year Department of Urology, Mayo Clinic Fellows' Association, 2012
- Join now to see all
Clinical Trials
- ADSTILADRIN (=INSTILADRIN) in Patients With High Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) Start of enrollment: 2016 Sep 19
- Evaluating Sexual Function in Women Undergoing a Radical Cystectomy for Bladder Cancer Start of enrollment: 2019 Sep 03
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 214 citationsAnatomic Features of Enhancing Renal Masses Predict Malignant and High-Grade Pathology: A Preoperative Nomogram Using the RENAL Nephrometry ScoreAlexander Kutikov, Marc C. Smaldone, Brian L. Egleston, Brandon J. Manley, Daniel Canter
European Urology. 2011-08-01 - 62 citationsImpact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy.Nicola Fossati, R. Jeffrey Karnes, Michele Colicchia, Stephen A. Boorjian, Alberto Bossi
European Urology. 2017-08-02 - 226 citationsSarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer‐specific and all‐cause mortalitySarah P. Psutka, Alonso Carrasco, Grant D. Schmit, Michael R. Moynagh, Stephen A. Boorjian
Cancer. 2014-09-15
Journal Articles
- Radical Versus Partial Nephrectomy for cT1 Renal Cell CarcinomaBoris Gershman, Stephen A Boorjian, Bradley C Leibovich, European Urology
- The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and TreatmentBimal Bhindi, Igor Frank, Aaron M Potretzke, Stephen A Boorjian, John C Cheville, Bradley C Leibovich, European Urology
- Temporal Trends in Venous Thromboembolism After Radical Cystectomy☆Matthew K Tollefson, Igor Frank, Stephen A Boorjian, Urologic Oncology
Authored Content
- A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous CohortsMay 2018
- Predicting Oncologic Outcomes in Renal Cell Carcinoma After SurgeryFebruary 2018
- Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-Term Results from a Large, Multi-Institutional SeriesDecember 2017
Press Mentions
FDA Approves First Gene Therapy for Non-Muscle-Invasive Bladder CancerDecember 16th, 2022- Clinical Trials for Bladder CancerSeptember 3rd, 2022
- Clinical Trials for Bladder CancerSeptember 1st, 2022
- Join now to see all
Committees
- Member, National Comprehensive Cancer Network Guideline Panel: Bladder Cancer/Penile Cancer 2014 - Present
Professional Memberships
- Member
- Member
- Society of Urologic OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
